Literature review
Allpediatric indications reviewed
Review the evidence
We identified every pediatric indication with relevance to abnormal VEGF mechanisms.
Case Study · Strategic Roadmap
Matching a VEGFR drug to pediatric needs.
A global biopharmaceutical company wanted to apply an oral VEGFR inhibitor to pediatric indications. We reviewed the literature, interviewed experts and scored every indication to find the highest market opportunity.
The Client
The client is a global biopharmaceutical company. It wanted to extend an oral VEGFR inhibitor to children.
The Challenge
One molecule.
Which children benefit most?
Prescouter was asked to identify pediatric indications where VEGF is overexpressed or where VEGF pathway inhibition could affect disease drivers, and to assess the clinical trial landscape.
-
Biology
VEGF overexpression
Find diseases driven by VEGF.
-
Need
Unmet clinical need
Pinpoint where value is highest.
-
Trials
Clinical trial landscape
Inform the strategic roadmap.
Our Approach
Scoring every indication against real need.
Expert interviews
Expertsclinical voices consulted
Find the need
Experts pinpointed indications with the largest unmet need and clinical value for an oral therapy.
Scoring matrix
Rankedindications scored
Rank the options
A scoring matrix singled out the indications with the highest market opportunity for the client.
The Outcome
A roadmap for pediatric expansion.
Prescouter delivered a series of detailed reports that guided how the client could apply its oral VEGFR inhibitor to pediatric indications. The reports informed its strategic roadmap and clarified how well biomarkers performed in clinical trials.
-
Focus
Top pediatric indications
Ranked by market opportunity.
-
Roadmap
Strategic direction
Reports that shaped next steps.
-
Biomarkers
Trial biomarker insight
Clarity on how well they work.
Repurposing a molecule for children raises the bar on evidence. A transparent scoring system keeps choices grounded in need and value.
Let’s Talk
Where else could your molecule make a difference?
Review the evidence, hear from clinicians and rank the options that matter. Wherever you’re starting from, we’ll help you get there.
Or email [email protected]